5Hallioglu O,Dilber E,Celiker A,et al.Comparison of acute hemodynamic effects of aeroaolized and intravenous iloprost in secondary pulmonary hypertension in children with congenital heart disease.Am J Cardiol,2003,92(8):1007-1009.
2BADESCH DB,ABMAN SH,AHEAM GS,et al.ACCP Evidencebased clinical practice guidelines.Medical therapy for pulmonary hypertension[J].Chest,2004,126 (Suppl):S35-S62.
3MCGOON M,GUTTERMAN D,STEEN V,et al.ACCP Evidence-based clinical practice guidelines.Screening,early detection and diagnosis of pulmonary hypertension[J].Chest,2004,126(Suppl):S14-S34.
4TUDER RM,COOL CD,GERACI MW,et al.Prostacyclin synthase expression is decreased in lungs from patients with severe pulmonary hypertension[J].Am J Respir Crit Care Med,1999,159(6):1925-1932.
5BARST RJ,RUBIN LJ,LONG WA,et al.Acomparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension.The Primary Pulmonary Hypertension Study Group[J].N Engl J Med,1996,334(5):296 -302.
6BADESCH DB,TAPSON VF,MCGOON MD,et al.Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease:a randomized,controlled trial[J].Ann Intern Med,2000,132 (6):425-434.
7BARST RJ,RUBIN LJ,MCGOON MD,et al.Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin[J].Ann Intern Med,1994,121 (6):409-415.
8KRAUSE W,KRAIS T.Pharmacokinetics and pharmacodynamics of the prostacyclin analogue iloprost in man[J].Eur J Clin Pharmacol,1986,30 (1):61-68.
9OLSCHEWSKI H,SIMONNEAU G,GALIE N,et al.Inhaled iloprost for severe pulmonary hypertension[J].N Engl J Med,2002,347 (5):322-329.
10HOEPER MM,SCHWARZE M,EHLERDING S,et al.Longterm treatment of primary pulmonary hypertension with aerosolized iloprost,a prostacyclin analogue[J].N Engl J Med,2000,342(25):1866-1870.
2Badesch DB,Abman SH,Ahearn GS,et al.Medical Therapy for Pulmonary Aaterial Hypertension:Updated ACCP Evidence-based Clinical Practice Guidelines.Chest,2007,131(6):1917-1928.
3Mcgoon M,Gutterman D,Steen V,et al.ACCP evindence-based clinical practice guidelines.Screening,early detection and diagnosis of pulmonary hypertension.Chest,2004,126(Suppl 1):S14-S34.
4Derliz M,Ralf E,Sven L,et al.Effect of inhaled iloprost during offmedication time in patients with pulmonary arterial hypertension.Respiration,2007,74:498-502.
5Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med,2002, 346 ( 15 ) : 1128-1137.
